Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
The Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025 has now ended. ¡Los vídeos están disponibles BAJO DEMANDA! Las versiones completas sin editar del Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón de agosto de 2025 ya están disponibles BAJO DEMANDA. Estos temas se editarán y se ofrecerán en forma de vídeos más cortos en las próximas semanas. Este evento educativo para pacientes, en directo, virtual e interactivo, incluye presentaciones y...
GRACE is pleased to announce the acceptance of four rising stars into the 7th year of the GRACE Patient Education Ambassadors Program for the 2025-26 Program Year! Applications for this program are open in March every year. To be notified when applications for this program open, please email Amy Bickleman, Executive Director, at abickleman@cancergrace.org to be added to the notification list. All four candidates have shown a genuine passion for patient education and innovation in connecting with...
Da click aquí para más información y para registrarte ahora Este 9 de agosto, no te puedes perder nuestro Foro anual de pacientes de terapias dirigidas de cáncer pulmón de GRACE en ESPAÑOL. Es un evento educativo para pacientes en vivo, virtual e interactivo, que incluye presentaciones y mesas redondas que cubren una diversa gama de cánceres de pulmón y opciones de tratamiento. Este evento educativo para pacientes, en directo, virtual e interactivo, incluye presentaciones y mesas redondas que...
GRACE is pleased to introduce three amazing individuals participating in the 2024-25 GRACE Clinical Trials Experiences Storytelling Program We are thrilled to introduce this year’s participants in the Clinical Trials Storytelling Program! Representing diverse cancer types and a range of clinical trial experiences, these incredible individuals will collaborate with GRACE to create meaningful content across multiple platforms. Through their stories, they will become established contributors...
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.